Reilly claims deal worth €400m on cost of drugs

The Health Minister James Reilly is claiming a deal on the cost of drugs that will be worth €400m over the next three years.

Reilly claims deal worth €400m on cost of drugs
Mon, 15 Oct, 2012 - 13:09

The Health Minister James Reilly is claiming a deal on the cost of drugs that will be worth €400m over the next three years.

The three-year deal will involve savings of €200m on the cost of drugs in the health service and mean cheaper drugs for people.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Status orange warning for Cork, Kerry, and Waterford as Met Éireann warns of 'extreme thunderstorm activity' Status orange warning for Cork, Kerry, and Waterford as Met Éireann warns of 'extreme thunderstorm activity'
Minister urges delay to water works in period of ‘extreme heat’ Minister urges delay to water works in period of ‘extreme heat’
'At least they'll have someone to converse with': Only two pupils enrolled in new gaelcholáiste 'At least they'll have someone to converse with': Only two pupils enrolled in new gaelcholáiste
CourtsHeathrowPlace: EuropePerson: ReillyPerson: Health MinisterPerson: James ReillyPerson: David GallagherPerson: Orlaith BrennanPerson: Commercial Affairs DirectorOrganisation: EUOrganisation: Irish Pharmaceutical Healthcare AssociationOrganisation: IPHAOrganisation: Ireland
<p>Denis Kennedy who gave evidence at the Defence Forces Tribunal on Thursday. Picture: Neil Michael.</p>

‘I walked into hell’: Recruit tells Defence Forces Tribunal of being ‘tortured, not trained’

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited